Hemin as a novel candidate for treating COVID-19 via heme oxygenase-1 induction

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the coronavirus disease-19 (COVID-19). More than 143 million cases of COVID-19 have been reported to date, with the global death rate at 2.13%. Currently, there are no licensed therapeutics for controlling SARS-Co...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Dong-Hwi, Ahn, Hee-Seop, Go, Hyeon-Jeong, Kim, Da-Yoon, Kim, Jae-Hyeong, Lee, Joong-Bok, Park, Seung-Yong, Song, Chang-Seon, Lee, Sang-Won, Ha, Sang-Do, Choi, Changsun, Choi, In-Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563742/
https://www.ncbi.nlm.nih.gov/pubmed/34728736
http://dx.doi.org/10.1038/s41598-021-01054-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563742/
https://www.ncbi.nlm.nih.gov/pubmed/34728736
http://dx.doi.org/10.1038/s41598-021-01054-3

Ejemplares similares